Form 4: Creative Medical Technology Holdings Director Sells Shares
SEC Form 4 Filing
Michael H. Finger, a director of Creative Medical Technology Holdings, Inc., sold a total of 1,500 shares of common stock in two transactions on February 18 and 19, 2025.
Summary
- On February 18, 2025, Michael H. Finger, a director of Creative Medical Technology Holdings, Inc., sold 750 shares of common stock at a price of $5 per share.
- Following this transaction, Mr. Finger directly owned 1,101 shares of the company's common stock.
- On February 19, 2025, Mr. Finger sold another 750 shares of common stock at a price of $5.75 per share.
- After the second transaction, Mr. Finger directly owned 351 shares of the company's common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock sales by a director, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of directors and officers, which can be relevant to investors.
Stakeholder Impact
- Shareholders may interpret the stock sale as a lack of confidence by the director, although it could be for personal financial reasons.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Director Michael H. Finger sold 750 shares of common stock at $5 per share. |
| 02/19/2025 | Director Michael H. Finger sold 750 shares of common stock at $5.75 per share. |
| 02/20/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC., CELZ, Michael H. Finger, Director, Stock Sale, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.